Paclitaxel belongs to the diterpenoid compounds and has good antitumor activity against various cancers such as ovarian cancer and breast cancer. Due to its poor solubility, paclitaxel has significant adverse reactions when it was used directly, limiting its clinical application. Serum albumin nanoparticles can compensate for the inherent defects of paclitaxel, enhance the stability of the drug in the body, improve its bioavailability and targeting ability, achieve the purpose of enhancing efficacy and reducing toxicity, and to some extent solve the problem of paclitaxel. This review summarizes the preparation process of serum albumin-paclitaxel nanoparticles, the application of modified serum albumin in paclitaxel-loaded nanoparticles, in order to provide theoretical guidance for the development of serum albumin based nanodrug delivery systems that meet actual clinical applications.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |